The number of people who have the gene that causes Huntington's disease in Northern Scotland has been accurately counted for ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

Northern Scotland has one of the highest rates of Huntington’s disease globally, according to new research from the University of Aberdeen. For the first time in 35 years, scientists have ...

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Huntington's Disease Treatment Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets ...

Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people living in the area who have the gene that causes the condition has been ...

Were you Seen at the 2025 Corks & Forks event benefiting the Huntington's Disease Society of America on March 28, 2025, at Duo at the Dunes in Albany? Empire Wine hosted the event. Were you Seen ...

Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people living in the area who have the gene that causes the condition has ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating Huntington's disease, a rare neurodegenerative condition. This designation ...

Northern Scotland has one of the highest rates of Huntington’s disease globally, according to new research from the University of Aberdeen. For the first time in 35 years, scientists have accurately ...